title: [Endourological treatment of aged high-risk patients with benign prostate hyperplasia: a report of 283 cases].
abstract: OBJECTIVE
  To evaluate the safety and effectiveness of endourological techniques in the treatment of benign prostate hyperplasia (BPH) in aged high-risk patients.
  
  
  METHODS
  We used endourological techniques in the treatment of 283 BPH patients aged over 70 years and complicated with hydronephrosis, renal failure, heart failure, cerebral infarction, respiratory dysfunction, anemia, diabetes, bladder tumor, or prostate weight over 80 g, TURP (transurethral resection of the prostate) for 112 cases and PKRP (transurethral plasmakinetic resection of the prostate) for the other 171. All the patients were followed up for 1-30 months.
  
  
  RESULTS
  In the TURP group, the scores on IPSS and QOL were decreased from 27.5 +/- 2.8, 5.5 +/- 1.0 to 5.8 +/- 1.2, 1.0 +/- 0.5, and the residual urine volume (RUV) from (75.0 +/- 20.0) ml to (8.0 +/- 3.0) ml, but the maximal flow rate (Qmax) increased from (6.5 +/- 2.0) ml/s to (18.5 +/- 1.5) ml/s (P < 0.05), while in the PKRP group, the scores on IPSS and QOL were decreased from 28.2 +/- 2.2, 5.5 +/- 1.0 to 5.4 +/- 1.6, 1.0 +/- 0.5, and RUV from (80.0 +/- 20.0) ml to (7.0 +/- 3.0) ml, and Qmax increased from (6.8 +/- 2.1) ml/s to (20.0 +/- 1.5) ml/s (P < 0.05). There were no statistically significant differences in IPSS, QOL, Qmax and RUV after treatment between the two groups (P > 0.05), but significantly less complications were found in the PKRP than in the TURP group (P < 0.05).
  
  
  CONCLUSIONS
  Endourological treatment, especially PKRP, with comprehensive perioperative preparations, unerring operative skills, well-controlled operation time, and intensive postoperative monitoring and nursing, has the advantages of high safety, less bleeding, fewer complications and definite effectiveness for aged high-risk BPH patients.
authors.affiliation: Department of Urology, Union Hospital, Tongfi Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China. wangliang_uh@hotmail.com
authors.forename: Liang
authors.initials: L
authors.lastname: Wang
authors.forename: Min
authors.initials: M
authors.lastname: Fan
authors.forename: Wen
authors.initials: W
authors.lastname: Ju
authors.forename: Zi-li
authors.initials: ZL
authors.lastname: Pang
authors.forename: Zhao-hui
authors.initials: ZH
authors.lastname: Zhu
authors.forename: Bing
authors.initials: B
authors.lastname: Li
authors.forename: Ya-jun
authors.initials: YJ
authors.lastname: Xiao
authors.forename: Fu-qing
authors.initials: FQ
authors.lastname: Zeng
authors.forename: Chuan-guo
authors.initials: CG
authors.lastname: Xiao
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000601:surgery*; D011788:Quality of Life; D020728:Transurethral Resection of Prostate / Q000379:methods*; D016896:Treatment Outcome